| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |